pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$VERXVertex, Inc.

$VERX13.58+0.44%
King Of Prussia, PA, USupdated 9h ago

Vertex, Inc. is a tax compliance software and services company based in King of Prussia, Pennsylvania, USA.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
20
marketed
7
phase 3
4
catalysts ytd
17
approvals ytd
12
recalls ytd
0

Pipeline(20)

view full pipeline →
pipeline depth20 products
Phase 2: 3Phase 3: 4Marketed: 7Unknown: 6
3Phase 24Phase 37Marketed6Unknown
Marketed
(deutivacaftor + tezacaftor + vanzacaftor calcium)
Cystic Fibrosis
Marketed
(elexacaftor + ivacaftor + tezacaftor) + ivacaftor
Cystic Fibrosis
Marketed
(ivacaftor + lumacaftor)
Cystic Fibrosis
Marketed
(ivacaftor + tezacaftor) + ivacaftor
Cystic Fibrosis
Marketed
TRIKAFTA (COPACKAGED)
Marketed
ivacaftor
Cystic Fibrosis
Marketed
suzetrigine
Diabetic Peripheral Neuropathy
Phase 3
exagamglogene autotemcel
Beta Thalassaemia
B-cell lymphoma/leukemia 11A
Phase 3
inaxaplin
Focal Segmental Glomerulosclerosis (FSGS)
Phase 3
povetacicept
Membranous Glomerulonephritis
Phase 3
zimislecel
Type 1 Diabetes (Juvenile Diabetes)
Phase 2
VC-01
Type 1 Diabetes (Juvenile Diabetes)

📅 Upcoming

Nov 2, 2026
earnings
$VERX13.58+0.44%
in 2mo
Vertex, Inc. earnings
Vertex, Inc.
→

🕒 Recent(90d)

earnings (2)
Aug 5, 2026
earnings
$VERX13.58+0.44%
16d ago
Vertex, Inc. earnings
Vertex, Inc.
→
Aug 3, 2026
earnings
$VERX13.58+0.44%
18d ago
Vertex, Inc. earnings
Vertex, Inc.
→
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Mar 9, 26BUYITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5, 2001· 10,000 sh @ $15.05$150K↗
  • Feb 23, 26BUYYoung Christopher David· President and CEO60,000 sh @ $12.18$731K↗
routine RSU / option mechanics (6)
  • Feb 24, 26tax coverDeStefano David · 51,983 sh
  • Feb 24, 26option exerciseDeStefano David · 109,233 sh
  • Feb 24, 26option exerciseDeStefano David · 109,233 sh
  • Feb 23, 26tax coverDeStefano David · 47,112 sh
  • Feb 23, 26tax coverSCHWAB JOHN R · CHIEF FINANCIAL OFFICER16,411 sh
  • Feb 23, 26tax coverRowland Bryan T.R. · GENERAL COUNSEL1,768 sh
🐶 Hiring Signal
next earnings Nov 2, 2026
No open roles indexed yet — view Vertex, Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$VERX
SEC CIK
0001806837
country
US
source
sec_tickers
top tags
Cystic Fibrosis6Pulmonology6Pain1Sickle Cell Disease1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 39m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?